[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Lin, 2021 - Google Patents

Regulation of hematopoiesis and B-lymphocyte development by histone deubiquitinases

Lin, 2021

View PDF
Document ID
5852652351207446635
Author
Lin Y
Publication year

External Links

Snippet

Hematopoiesis, or the production of all blood cells from a rare population of hematopoietic stem cells (HSCs), is a tightly regulated process that replenishes our blood and immune systems throughout life. In the pool of blood cells, B cells are crucial in the adaptive immune …
Continue reading at escholarship.mcgill.ca (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0647Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology

Similar Documents

Publication Publication Date Title
Horton et al. Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors
Gekas et al. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1
Pham et al. STAT5B N642H is a driver mutation for T cell neoplasia
Han et al. Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice
JP2019512271A (en) T cell exhaustion state specific gene expression regulator and use thereof
Tooze A replicative self-renewal model for long-lived plasma cells: questioning irreversible cell cycle exit
Kishimoto et al. Molecular pathogenesis of follicular lymphoma
Lin et al. Regulation of B lymphocyte development by histone H2A deubiquitinase BAP1
Man et al. p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia
Welsh et al. Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma
AU2019269318A1 (en) Manipulating ARID5B expression in immune cells to promote metabolism, survival, and function
Lin Regulation of hematopoiesis and B-lymphocyte development by histone deubiquitinases
WO2017049002A1 (en) A humanized mouse model of de novo human acute myeloid leukemia with a matching human immune system
Li et al. Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B cell fate decisions and yields T cell-depleted lymphomas
Suske et al. Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia
Garton Functions of ARID3a in multiple hematopoietic cell types
Van Thillo Oncogenic cooperation in T-cell acute lymphoblastic leukemia: the role of TLX3 and TCF7-SPI1
Kirkpatrick The Role of ETV6 Germline Mutations in B Cell Development and Predisposition to Leukemia
Qiling Hematopoietic Stem Cell Integrity Is Dependent on Znf143 Maintenance of Chromosome Structure
WO2023230507A2 (en) Harnessing ikzf:beta-catenin complexes in the treatment of lymphocyte associated diseases or conditions
Krutein Molecular genetics of myeloid malignancy predisposition: Insights into pathogenesis and therapeutic translation
Östlund The Translocation t (7; 12)(q36; p13) in Childhood Acute Myeloid Leukemia
Rajagopalan A Tale of Two Codons: Synergistic Mechanisms in Oncogenic Nras Induced Hematological Malignancies
Huang Molecular pathology of splicing and transcription factor mutations in myelodysplastic syndromes
Lin et al. Decreased RNA‐binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide